EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Gut Microbiota and Hepatocellular Carcinoma

Xueme Tao, Nin Wang, Wenxi Qin

Gastrointestinal Tumors · 2015 · 2 (1) · 33-40

DOI: 10.1159/000380895 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Gastrointestinal Tumors, online erschienen am 22.04.2015. Verfasst von Xueme Tao und 2 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Sha…. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: Hepatocellular carcinoma (HCC) is a common complication of liver diseases such as those related to viral hepatitis and liver cirrhosis. The gut-liver axis is gaining increasing attention as a key pathophysiological mechanism responsible for the progression of HCC. Here, we will review the data from the published literature to address the association between HCC and gut microbiota. Summary: The presence of high levels of endotoxemia in the blood results in portal hypertension and ensuing hepatocyte damage, thus leading to the development of HCC. Probiotics can be used to treat or prevent the progression of HCC, because they may decrease the counts of gut microbiota and thus improve the endotoxemia. Key Message: Increased bacterial translocation can result in endotoxemia, which may play a critical role in the progression of HCC. Modulation of the gut microbiota by probiotics may represent a new avenue for therapeutic intervention in HCC. Practical Implications: Breakdown in intestinal barrier function and bacterial overgrowth are main events in the development of HCC. When the intestinal barrier function is disrupted, large amounts of bacterial products can enter the liver and induce inflammation through their receptors, leading to liver diseases. Altering the gut microflora has been proposed as an adjunctive therapy to reduce bacterial translocation and prevent progression of HCC. The purpose of this review is to discuss the relationship between gut microbiota and HCC in both pathogenesis and treatment by probiotics.

Schlagwörter

Stichwörter der Autor:innen

EndotoxemiaGut microbiotaGut-liver axisHepatocellular carcinomaProbiotics

Autor:innen und Institutionen

  • State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Zitieren

APA

Tao, X., Wang, N., & Qin, W. (2015). Gut Microbiota and Hepatocellular Carcinoma. Gastrointestinal Tumors, 2(1), 33-40. https://doi.org/10.1159/000380895

Vancouver

Tao X, Wang N, Qin W. Gut Microbiota and Hepatocellular Carcinoma. Gastrointestinal Tumors. 2015;2(1):33-40. doi:10.1159/000380895

BibTeX
@article{Tao2015,
  author = {Tao, Xueme and Wang, Nin and Qin, Wenxi},
  title = {Gut Microbiota and Hepatocellular Carcinoma},
  journal = {Gastrointestinal Tumors},
  year = {2015},
  volume = {2},
  number = {1},
  pages = {33--40},
  doi = {10.1159/000380895}
}
Kostenlos starten →